155 related articles for article (PubMed ID: 2969663)
1. Vasorelaxant and natriuretic activities of synthetic atrial peptides.
Januszewicz A; Pegram BL; Macphee AA; Cole FE; Kardon MB; Trippodo NC
Acta Physiol Pol; 1987; 38(6):467-76. PubMed ID: 2969663
[TBL] [Abstract][Full Text] [Related]
2. Ontogeny of responses of rabbit aorta to atrial natriuretic factor and isoproterenol.
Chemtob S; Guest I; Potvin W; Varma DR
Dev Pharmacol Ther; 1991; 16(2):108-15. PubMed ID: 1833168
[TBL] [Abstract][Full Text] [Related]
3. Effects of sodium pump inhibition on the relaxation induced by synthetic atrial natriuretic factor (ANF) and sodium nitroprusside.
Auguet M; Delaflotte S; Garay R; Cantin M; Clostre F; Braquet P
Regul Pept Suppl; 1985; 4():107-9. PubMed ID: 2414808
[No Abstract] [Full Text] [Related]
4. Atriopeptins: bioactive peptides derived from mammalian cardiac atria.
Currie MG; Geller DM; Cole BR; Siegel NR; Fok KK; Adams SP; Eubanks SR; Galluppi GR; Needleman P
J Hypertens Suppl; 1984 Dec; 2(3):S309-12. PubMed ID: 6242557
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.
Willenbrock RC; Tremblay J; Garcia R; Hamet P
J Clin Invest; 1989 Feb; 83(2):482-9. PubMed ID: 2536399
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of alpha-human atrial natriuretic peptide.
Watanabe TX; Noda Y; Chino N; Nishiuchi Y; Kimura T; Sakakibara S; Imai M
Eur J Pharmacol; 1988 Feb; 147(1):49-57. PubMed ID: 2967190
[TBL] [Abstract][Full Text] [Related]
7. [Comparative pharmacological characteristics of peptides of the atrial natriuretic factor family].
Bespalova ZhD; Vinogradov VA; Zhukovskiĭ SV; Kaĭkov MI; Korobov NV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):86-9. PubMed ID: 2969737
[TBL] [Abstract][Full Text] [Related]
8. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
9. [Interaction of atrial natriuretic factor and cicletanine in relation to contractions induced by endothelin and phenylephrine on the isolated rat aorta].
Auguet M; Delaflotte S; Braquet P
Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():59-62. PubMed ID: 2532880
[TBL] [Abstract][Full Text] [Related]
10. Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta.
Linz W; Albus U; Wiemer G; Schölkens BA; König W
Klin Wochenschr; 1986; 64 Suppl 6():27-30. PubMed ID: 3025511
[TBL] [Abstract][Full Text] [Related]
11. Possible mechanisms underlying the vasorelaxant response to atrial natriuretic factor.
Winquist RJ
Fed Proc; 1986 Aug; 45(9):2371-5. PubMed ID: 3015691
[TBL] [Abstract][Full Text] [Related]
12. Human atrial natriuretic polypeptides (hANP): purification, structure synthesis and biological activity.
Kangawa K; Fukuda A; Kubota I; Hayashi Y; Minamitake Y; Matsuo H
J Hypertens Suppl; 1984 Dec; 2(3):S321-3. PubMed ID: 6242560
[TBL] [Abstract][Full Text] [Related]
13. The role of Na+-K+ -ATPase in the vasorelaxant actions of synthetic atrial natriuretic factor.
Sybertz EJ; Desiderio DM
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):142-9. PubMed ID: 2420296
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic factors (ANF) and antidiuretic agents.
Croxatto HR; Rosas R
Acta Physiol Pharmacol Latinoam; 1988; 38(1):1-9. PubMed ID: 2974232
[TBL] [Abstract][Full Text] [Related]
15. Comparative biological activities of ANF (Arg 101-Tyr 126) and the synthetic form of circulating ANF (Ser 99-Tyr 126).
Garcia R; Cantin M; De Léan A; Genest J; Godin J; Gutkowska J; Schiffrin EL; Thibault G
Biochem Biophys Res Commun; 1986 Mar; 135(3):987-93. PubMed ID: 2938586
[TBL] [Abstract][Full Text] [Related]
16. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
17. The biological activity of atrial natriuretic factor cleaved by endoprotease 3.4.24.11.
Ghai RD; Webb RL; Sonnenberg JL; Sakane Y; Ghai G
J Enzyme Inhib; 1991; 4(3):267-72. PubMed ID: 1645400
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and renal effects of atrial natriuretic factor in portal hypertensive rats. Potentiation by Phe-Ile-Orn-vasopressin.
Ganger DR; Gottstein J; Blei AT
J Pharmacol Exp Ther; 1988 Sep; 246(3):941-5. PubMed ID: 2971104
[TBL] [Abstract][Full Text] [Related]
19. Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin.
Trippodo NC; MacPhee AA; Cole FE
J Hypertens Suppl; 1984 Dec; 2(3):S289-91. PubMed ID: 6242556
[TBL] [Abstract][Full Text] [Related]
20. Comparative vascular pharmacology of the atriopeptins.
Wakitani K; Oshima T; Loewy AD; Holmberg SW; Cole BR; Adams SP; Fok KF; Currie MG; Needleman P
Circ Res; 1985 Apr; 56(4):621-7. PubMed ID: 3156691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
